Omeros Corporation
OMER
#6157
Rank
A$1.48 B
Marketcap
A$19.96
Share price
-5.71%
Change (1 day)
45.11%
Change (1 year)

Earnings for Omeros Corporation (OMER)

Earnings in 2026 (TTM): A$19.92 Million

According to Omeros Corporation's latest financial reports the company's current earnings are A$38.42 Million. In 2025 the company made an earning of -A$0.18 Billion, an increase over its 2024 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Omeros Corporation from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$19.92 M-111.44%
2025 -A$0.18 Billion-27.03%
2024 -A$0.24 Billion9.63%
2023 -A$0.22 Billion-9.57%
2022 -A$0.25 Billion-30.65%
2021 -A$0.35 Billion86.28%
2020 -A$0.19 Billion99.45%
2019 -A$93.42 Million-49.91%
2018 -A$0.19 Billion190.77%
2017 -A$64.14 Million-27.96%
2016 -A$89.03 Million-17.61%
2015 -A$0.11 Billion1.88%
2014 -A$0.11 Billion87.56%
2013 -A$56.55 Million
2011 -A$41.42 Million-8.96%
2010 -A$45.49 Million45.03%
2009 -A$31.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$28.28 B 117,067.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$10.52 B 43,509.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
-A$5.84 Million-124.19%๐Ÿ‡ฆ๐Ÿ‡บ Australia
Eterna Therapeutics
ERNA
-A$24.96 Million-203.39%๐Ÿ‡บ๐Ÿ‡ธ USA